✉ Email this page to a colleague
« Back to Dashboard
Tofisopam is an investigational drug.
There have been 3 clinical trials for Tofisopam. The most recent clinical trial was a Phase 2 trial, which was initiated on May 28th 2018.
The most common disease conditions in clinical trials are Dyslipidemias, Hyperuricemia, and Gout. The leading clinical trial sponsors are Pharmos, Instituto Nacional de Salud Publica, Mexico, and Laboratorios Grossman, S.A.
Recent Clinical Trials for Tofisopam
|Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population||Instituto Nacional de Salud Publica, Mexico||Phase 3|
|Clinical Trial to Evaluate the Efficacy of a Dyslipidemic Therapy in Mexican Population||Laboratorios Grossman, S.A.||Phase 3|
|Study of Levotofisopam 50 mg Three Times a Day (TID) Administered for 7 Days on Hyperuricemia and Gout||Pharmos||Phase 2|